Advertisement
Singapore markets closed
  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • FTSE 100

    7,828.01
    -49.04 (-0.62%)
     
  • Bitcoin USD

    64,762.68
    +3,327.21 (+5.42%)
     
  • CMC Crypto 200

    1,332.09
    +19.47 (+1.51%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • Dow

    37,775.38
    +22.07 (+0.06%)
     
  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     
  • Gold

    2,396.50
    -1.50 (-0.06%)
     
  • Crude Oil

    83.19
    +0.46 (+0.56%)
     
  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     
  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     
  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Top Ranked Momentum Stocks to Buy for February 4th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 4th:

RLI Corp. (RLI): This is an insurance holding company, underwrites property and casualty insurance has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.

RLI Corp. Price and Consensus

RLI Corp. Price and Consensus
RLI Corp. Price and Consensus

RLI Corp. price-consensus-chart | RLI Corp. Quote

RLI’s shares gained 3.1% over the last one month over the S&P 500’s growth of 0.1%. The company possesses a Momentum Score of A.

RLI Corp. Price

RLI Corp. Price
RLI Corp. Price

RLI Corp. price | RLI Corp. Quote

ADVERTISEMENT

Mellanox Technologies, Ltd. (MLNX): This is a fabless semiconductor company, designs, manufactures, markets, and sells interconnect products and solutions has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.8% over the last 60 days.

Mellanox Technologies, Ltd. Price and Consensus

Mellanox Technologies, Ltd. Price and Consensus
Mellanox Technologies, Ltd. Price and Consensus

Mellanox Technologies, Ltd. price-consensus-chart | Mellanox Technologies, Ltd. Quote

Mellanox Technologies’ shares gained 1.8% over the last one month. The company possesses a Momentum Score of A.

Mellanox Technologies, Ltd. Price

Mellanox Technologies, Ltd. Price
Mellanox Technologies, Ltd. Price

Mellanox Technologies, Ltd. price | Mellanox Technologies, Ltd. Quote

Xenon Pharmaceuticals Inc. (XENE): This ís a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 29.7% over the last 60 days.

Xenon Pharmaceuticals Inc. Price and Consensus

Xenon Pharmaceuticals Inc. Price and Consensus
Xenon Pharmaceuticals Inc. Price and Consensus

Xenon Pharmaceuticals Inc. price-consensus-chart | Xenon Pharmaceuticals Inc. Quote

Xenon Pharmaceuticals shares gained 4.8% over the last one month. The company possesses a Momentum Score of B.

Xenon Pharmaceuticals Inc. Price

Xenon Pharmaceuticals Inc. Price
Xenon Pharmaceuticals Inc. Price

Xenon Pharmaceuticals Inc. price | Xenon Pharmaceuticals Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.7% per year. So be sure to give these hand-picked 7 your immediate attention.

See 7 handpicked stocks now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Xenon Pharmaceuticals Inc. (XENE) : Free Stock Analysis Report
 
RLI Corp. (RLI) : Free Stock Analysis Report
 
Mellanox Technologies, Ltd. (MLNX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research